Orthofix Medical/$OFIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orthofix Medical
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
Ticker
$OFIX
Sector
Primary listing
Employees
1,605
Headquarters
Website
Orthofix Medical Metrics
BasicAdvanced
$471m
-
-$1.51
0.79
-
Price and volume
Market cap
$471m
Beta
0.79
52-week high
$16.99
52-week low
$10.24
Average daily volume
277k
Financial strength
Current ratio
2.866
Quick ratio
1.602
Long term debt to equity
59.522
Total debt to equity
60.263
Interest coverage (TTM)
-2.39%
Profitability
EBITDA (TTM)
17.004
Gross margin (TTM)
71.01%
Net profit margin (TTM)
-7.27%
Operating margin (TTM)
-5.39%
Effective tax rate (TTM)
-0.83%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
-3.25%
Return on equity (TTM)
-13.43%
Valuation
Price to revenue (TTM)
0.563
Price to book
1.08
Price to tangible book (TTM)
2.75
Price to free cash flow (TTM)
-105.143
Free cash flow yield (TTM)
-0.95%
Free cash flow per share (TTM)
-0.111
Growth
Revenue change (TTM)
2.59%
Earnings per share change (TTM)
-59.29%
3-year revenue growth (CAGR)
15.95%
10-year revenue growth (CAGR)
7.37%
3-year earnings per share growth (CAGR)
-21.94%
10-year earnings per share growth (CAGR)
11.75%
What the Analysts think about Orthofix Medical
Analyst ratings (Buy, Hold, Sell) for Orthofix Medical stock.
Orthofix Medical Financial Performance
Revenues and expenses
Orthofix Medical Earnings Performance
Company profitability
Orthofix Medical News
AllArticlesVideos
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
Business Wire·5 days ago
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
Business Wire·2 weeks ago
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Orthofix Medical stock?
Orthofix Medical (OFIX) has a market cap of $471M as of May 11, 2026.
What is the P/E ratio for Orthofix Medical stock?
The price to earnings (P/E) ratio for Orthofix Medical (OFIX) stock is 0 as of May 11, 2026.
Does Orthofix Medical stock pay dividends?
No, Orthofix Medical (OFIX) stock does not pay dividends to its shareholders as of May 11, 2026.
When is the next Orthofix Medical dividend payment date?
Orthofix Medical (OFIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Orthofix Medical?
Orthofix Medical (OFIX) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.